[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334983-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334983-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","biological-functions-and-potential-mechanisms-of-mir-143-3p-in-cancers-review","Biological functions and potential mechanisms of miR-143-3p in cancers - Review","","MicroRNAs have attracted increasing research attention for their involvement in cancer and their potential as biomarkers. miR-143-3p (and miR-143-5p) are mature microRNAs derived from pre-miRNA-143. Although many studies address miR-143-3p during cancer progression, comprehensive systematic reviews of its roles remain limited. This review summarizes miR-143-3p biogenesis, biological functions, and mechanisms across cancer types. It highlights its downregulation in most malignancies, upstream regulation, target gene effects, pathway involvement (PI3K/Akt, Wnt/β-catenin, AKT/STAT3, Ras-Raf-MEK-ERK), and future biomarker research directions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/biological-functions-and-potential-mechanisms-of-mir-143-3p-in-cancers-review/334983/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/biological-functions-and-potential-mechanisms-of-mir-143-3p-in-cancers-review/334983.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is miR-143-3p and where does it originate?","Question",{"text":63,"@type":64},"miR-143-3p is a mature microRNA derived from pre-miRNA-143. Its production follows sequential processing from pri-miRNA to pre-miRNA in the nucleus and to mature miRNA in the cytoplasm.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does miR-143-3p influence tumor biology?",{"text":68,"@type":64},"miR-143-3p is frequently downregulated in many malignant tumors. Through regulation of target genes, it affects tumor processes such as proliferation, migration, apoptosis, survival, and metastasis via multiple signaling pathways.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is miR-143-3p considered a potential cancer biomarker?",{"text":72,"@type":64},"The review emphasizes that miR-143-3p shows diagnostic and prognostic relevance in malignant tumors. It also discusses its possible upstream regulation and downstream targeting that connect it to cancer-specific biological changes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334983,1790698875,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","ONCOLOGY REPORTS 52: 113, 2024  \nBiological functions and potential mechanisms of miR‑143‑3p in cancers (Review)  \nJIA WU 1 , YING ZHU 1 , DANDAN LIU 1 , QINGWEI CONG 1 and CHANGCHUAN BAI2  \n1Department of Infectious Diseases, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116000, 2  \nP.R. China; Dalian Hospital of Traditional Chinese Medicine, Dalian, Liaoning 116013, P.R. China  \nReceived February 12, 2024; Accepted May 20, 2024  \nDOI: 10. 3892/or.2024.8772  \nAbstract. In recent years, microRNAs (miRNAs or miRs) have been increasingly studied for their role in cancer and have shown potential as cancer biomarkers . miR‑143‑3p and miR‑143‑5p are the mature miRNAs derived from pre‑miRNA‑143. At present, there are numerous studies on the function of miR‑143‑3p in cancer progression, but there are no systematic reviews describing the function of miR‑143‑3p in cancer. It is widely considered that miR‑143‑3p is downregu‑ lated in most malignant tumors and that upstream regulators can act on this gene, which in turn regulates the corresponding target to act on the tumor. In addition, miRNA‑143‑3p can regulate target genes to affect the biological process of tumors through various signaling pathways, such as the PI3K/Akt, Wnt/β‑catenin, AKT/STAT3 and Ras‑Raf‑MEK‑ERK path‑ ways . The present review comprehensively described the biogenesis of miR‑143‑3p, the biological functions of miR‑143‑3p and the related roles and mechanisms in different cancer types . The potential of miR‑143‑3p as a biomarker for cancer was also highlighted and valuable future research directions were discussed.  \nContents  \n1. Introduction  \n2. Biogenesis of miR‑143‑3p  \n3. Regulation and effect of miR‑143‑3p expression  \n4. Mechanism of miR‑143‑3p  \n5. Potential application of miR‑143‑3p in future practice  \n6. Discussion  \nCorrespondence to: Professor Ying Zhu, Department of Infectious Diseases, The First Affiliated Hospital of Dalian Medical University, 222 Zhongshan Road, Xigang, Dalian, Liaoning 116000, P.R. China  \nE‑mail: [zhuyingsh52@126.com](zhuyingsh52@126.com)  \nKey words: microRNA‑143‑3p, cancer, mechanism, biomarker, therapy  \n1. Introduction  \nThe 2020 Global Cancer Statistics report stated that there were 19.3 million new cancer cases and almost 10 million cancer‑related deaths in 2020 (1) . Previous research has suggested that there will be 22.2 million new cases among all cancer types in 2030, and cancer will continue to be the principal cause of increasing morbidity and mortality in all regions of the world for decades to come (2,3) . However, early screening for cancer is still not widespread, therefore numerous patients are diagnosed in the late stage, at which point radical treatments such as surgery are not ideal; thus, late diagnosis markedly reduces the survival rate of patients. Recently, an increasing number of new therapeutic methods, such as natural killer cell‑based cancer immunotherapy (4), RAS‑targeted cancer therapy (5) and immune checkpoint inhibitor (ICI) therapy, have been developed (6) . Although the discovery of ICIs represents a major breakthrough in cancer therapy, there are still some patients who are unresponsive to treatment or who cannot tolerate the side effects. Therefore, identifying more effective treatments is crucial for improving patient prognosis.  \nIn humans, >2,600 mature microRNA (miRNA or miR) sequences have been identified (7) . MiRNAs are small non‑coding RNAs that are ~19‑25 nucleotides in length and negatively modulate gene expression by base pairing to the 3'‑untranslated region (UTR) of target messenger RNAs (mRNAs) . They are usually abnormally expressed in tumor cells and can modulate the apoptosis, proliferation, survival and metastasis of cancer cells (8‑10). It is considered by numerous scholars (11‑13) that abnormal expression of miR‑143‑3p in malignant tumors plays a crucial role in tumor progression and can also act as a diagnostic and prognostic marker; it has eve","cbCaiiYbNYhaAXWo","https://ap.wps.com/l/cbCaiiYbNYhaAXWo","pdf",1598637,13,"English","# Introduction\n# Biogenesis of miR-143-3p\n# Regulation and effect of miR-143-3p expression\n# Mechanism of miR-143-3p\n# Potential application of miR-143-3p in future practice\n# Discussion","[{\"question\":\"What is miR-143-3p and where does it originate?\",\"answer\":\"miR-143-3p is a mature microRNA derived from pre-miRNA-143. Its production follows sequential processing from pri-miRNA to pre-miRNA in the nucleus and to mature miRNA in the cytoplasm.\"},{\"question\":\"How does miR-143-3p influence tumor biology?\",\"answer\":\"miR-143-3p is frequently downregulated in many malignant tumors. Through regulation of target genes, it affects tumor processes such as proliferation, migration, apoptosis, survival, and metastasis via multiple signaling pathways.\"},{\"question\":\"Why is miR-143-3p considered a potential cancer biomarker?\",\"answer\":\"The review emphasizes that miR-143-3p shows diagnostic and prognostic relevance in malignant tumors. It also discusses its possible upstream regulation and downstream targeting that connect it to cancer-specific biological changes.\"}]","Biological functions and potential mechanisms of miR-143-3p in cancers - Review | PDF",1790009133,33]